Prevention of venous thromboembolism
150 results
101 - 150
Acute treatment of traumatic spinal cord injuries - Dabigatran versus LMWHs for thromboprophylaxis after total hip or knee replacement
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy- Superficial venous thrombophlebitis
Rosuvastatin prevents DVT at very high cost- Warfarin therapy
- Direct oral anticoagulants
- Different types of intermittent pneumatic compression devices for preventing venous thromboembolism in patients after total hip replacement: Cochrane systematic review
- Standard‐ versus extended‐duration anticoagulation for primary venous thromboembolism prophylaxis in acutely ill medical patients
- Aspirin as safe and effective as LMWH for extended thromboprophylaxis after THA
- Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity
- Hormone therapy for preventing cardiovascular disease in post‐menopausal women
- Antithrombotic agents in primary health care
- Overweight in pregnancy
- Long‐term hormone therapy for perimenopausal and postmenopausal women
- Hormone therapy for preventing cardiovascular disease in post-menopausal women
- Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty: Cochrane systematic review
- Semi‐recumbent position versus supine position for the prevention of ventilator‐associated pneumonia in adults requiring mechanical ventilation
- Temporary IVC filter added to anticoagulation does not decrease risk of PE recurrence
- Low-molecular-weight heparins vs. standard heparin for acute ischaemic stroke
- Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism
- Unfractionated heparin versus low molecular weight heparins for avoiding heparin‐induced thrombocytopenia in postoperative patients
- Lower leg fractures
- Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia
- Methods for administering subcutaneous heparin during pregnancy
- Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss
- Strontium ranelate for preventing and treating postmenopausal osteoporosis
- Graduated compression stockings for prevention of deep vein thrombosis
- Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism
- Prophylactic anticoagulants for non‐hospitalised people with COVID‐19
- Menopausal symptoms and hormone therapy
- Thiazide diuretics and the risk of hip fracture: Cochrane systematic review
- Adder (Vipera berus) bite
- Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis
- Anticoagulants for people hospitalised with COVID‐19
- Dopamine agonists for preventing ovarian hyperstimulation syndrome
- Deep vein thrombosis
- COVID-19 and other coronavirus infections